Aastrom's Shocking News And Future Potential [View article]
Jason you could have been a hero . If you investigate instead of drinking the Kool Aid .
jill @biome123 4 Oct @JNapodano WTF cut & run when things get tough but make sure you line ur pockets first. Way to go Tim Collapse 1:56 PM - 4 Oct 12 · Details Jason Napodano, CFA @JNapodano 4 Oct @biome123 That makes no sense. Tim is a major shareholder and the stock is at a low. This doesn't look like a "cut and run" at the top. Hide conversation Reply Retweet Favorite More 2:31 PM - 4 Oct 12 · Details Tweet text Reply to @JNapodano Image will appear as a link jill @biome123 4 Oct @JNapodano what l am talking about is CLI is facing tough enrollment so he is bailing to let someone else take the fall . Expand Jason Napodano, CFA @JNapodano 4 Oct @biome123 They are guiding to 12-18 months. If you believe it will take that long, you should buy puts. Lots of them. View conversation jill @biome123 4 Oct @JNapodano after some D diligence on my part it may take ASTM 5y or longer to fill the rolls for ph3 is there a path forward Expand Jason Napodano, CFA @JNapodano 4 Oct @biome123 I dont understand. You're saying you think it will take 5yr to enroll the p3 trial? Hide conversation Reply Retweet Favorite More 7:42 AM - 4 Oct 12 · Details Tweet text Reply to @JNapodano Image will appear as a link jill @biome123 4 Oct @JNapodano Yes the criteria they agreed to is so tight the Patient’s r simply not there Expand Reply Delete Favorite More Jason Napodano, CFA @JNapodano 4 Oct @biome123 They are guiding to 12-18 months. If you believe it will take that long, you should buy puts. Lots of them Less
Is any body putting a gun to your head and telling to pluck down your money on ASTM . If not why are wasting your time bashing every time an article comes out . What is your motive . I am guessing that you would love to invest but just short on cash . If so tell us we will pass the hat for you .
Sell-Off Creates Opportunity in Aastrom Bio [View article]
Hey Jason
Looking at Asstrom's patent platform . Does the platform lend itself to licensing by others in the cell therapy arena . If so are you aware of any discussion by the ASTM to do so.
Aastrom's Shocking News And Future Potential [View article]
jill @biome123 4 Oct
@JNapodano WTF cut & run when things get tough but make sure you line ur pockets first. Way to go Tim
Collapse
1:56 PM - 4 Oct 12 · Details
Jason Napodano, CFA @JNapodano 4 Oct
@biome123 That makes no sense. Tim is a major shareholder and the stock is at a low. This doesn't look like a "cut and run" at the top.
Hide conversation Reply Retweet Favorite More
2:31 PM - 4 Oct 12 · Details
Tweet text
Reply to @JNapodano
Image will appear as a link
jill @biome123 4 Oct
@JNapodano what l am talking about is CLI is facing tough enrollment so he is bailing to let someone else take the fall .
Expand
Jason Napodano, CFA @JNapodano 4 Oct
@biome123 They are guiding to 12-18 months. If you believe it will take that long, you should buy puts. Lots of them.
View conversation
jill @biome123 4 Oct
@JNapodano after some D diligence on my part it may take ASTM 5y or longer to fill the rolls for ph3 is there a path forward
Expand
Jason Napodano, CFA @JNapodano 4 Oct
@biome123 I dont understand. You're saying you think it will take 5yr to enroll the p3 trial?
Hide conversation Reply Retweet Favorite More
7:42 AM - 4 Oct 12 · Details
Tweet text
Reply to @JNapodano
Image will appear as a link
jill @biome123 4 Oct
@JNapodano Yes the criteria they agreed to is so tight the Patient’s r simply not there
Expand Reply Delete Favorite More
Jason Napodano, CFA @JNapodano 4 Oct
@biome123 They are guiding to 12-18 months. If you believe it will take that long, you should buy puts. Lots of them Less
Aastrom Bio: Final RESTORE Data Looks Solid [View article]
BioTime (BTX) reports on 5 GMP-Compliant Human Embryonic Stem Cell Lines [View instapost]
Bullish on Aastrom [View article]
Is any body putting a gun to your head and telling to pluck down your money on ASTM . If not why are wasting your time bashing every time an article comes out . What is your motive . I am guessing that you would love to invest but just short on cash . If so tell us we will pass the hat for you .
Bullish on Aastrom [View article]
Jason
Would you raise your target for ASTM if a partner is confirmed .
Sell-Off Creates Opportunity in Aastrom Bio [View article]
Aastrom (ASTM) Manufacturing Transfer and CLI Product Naming [View instapost]
Sell-Off Creates Opportunity in Aastrom Bio [View article]
Good Morning Jason
Does today's news about generic naming have anything to do with platform licensing.
Sell-Off Creates Opportunity in Aastrom Bio [View article]
Does today's news about generic naming have anything to do with platform licensing.
Sell-Off Creates Opportunity in Aastrom Bio [View article]
Looking at Asstrom's patent platform . Does the platform lend itself to licensing by others in the cell therapy arena . If so are you aware of any discussion by the ASTM to do so.
Sell-Off Creates Opportunity in Aastrom Bio [View article]
picked this one of the floor at 2.08 . Was feeling great then I saw the the rank # . Needless to say it was restless night.
Sell-Off Creates Opportunity in Aastrom Bio [View article]
I am a bit confused this morning . I went to the Zacks web site . The rating on ASTM is a strong sell . Please advise
Good News for Aastrom Bio: IMPACT-DCM Trials Show Proof-of-Concept [View article]
I saw some where that you have a call in to Astrom tomorrow. If true can you press on ex US rights..
Good News for Aastrom Bio: IMPACT-DCM Trials Show Proof-of-Concept [View article]
Are u aware of any negotiations ongoing for a partnership outside the US For DCM . I hear a lot of noise about India and Germany .